Gritstone bio, Inc. (GRTS) - Stock Prices, Stock Peers & Analysis

Home
GRTS

Company Name	Gritstone bio, Inc.
Symbol	GRTS
Currency	USD
Price	0.467
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	55,168,714
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.42 - 3.33
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Website	https://gritstonebio.com

An error occurred while fetching data.

About Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers.